Supreme Court Sides with Teva on Drug Patent

The U.S. Supreme Court ruled that Teva Pharmaceutical Industries still has patent protection for top-selling multiple sclerosis drug Copaxone.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news